What is he best known for?
The fields of study he is best known for:
- Enzyme
- Receptor
- Biochemistry
Karl-Norbert Klotz spends much of his time researching Receptor, Adenosine receptor, Adenosine, Biochemistry and Adenosine A1 receptor.
Many of his studies on Receptor apply to Stereochemistry as well.
His studies deal with areas such as Endocrinology and Pharmacology as well as Adenosine receptor.
His study in Adenosine is interdisciplinary in nature, drawing from both Cell, Cancer research, Cyclase, Signal transduction and Adenosine receptor antagonist.
Biochemistry connects with themes related to Transfection in his study.
His Adenosine A1 receptor research is multidisciplinary, relying on both Molecular biology, Cell cycle and Growth factor receptor.
His most cited work include:
- International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors (2203 citations)
- Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells (704 citations)
- 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors. (358 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Adenosine receptor, Receptor, Stereochemistry, Adenosine and Biochemistry.
His Adenosine receptor study combines topics in areas such as Adenylyl cyclase and Pharmacology.
His Receptor research incorporates elements of Signal transduction and Binding site.
He interconnects Structure–activity relationship and Chemical synthesis in the investigation of issues within Stereochemistry.
His work in Adenosine tackles topics such as Adenosine A3 receptor which are related to areas like Purinergic signalling.
The concepts of his Agonist study are interwoven with issues in Antagonist and Ligand.
He most often published in these fields:
- Adenosine receptor (76.92%)
- Receptor (51.58%)
- Stereochemistry (43.44%)
What were the highlights of his more recent work (between 2016-2021)?
- Adenosine receptor (76.92%)
- Receptor (51.58%)
- Stereochemistry (43.44%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Adenosine receptor, Receptor, Stereochemistry, Adenosine and Pharmacology.
Karl-Norbert Klotz has researched Adenosine receptor in several fields, including Antagonist, Molecular model, Docking and Xanthine.
His Receptor study introduces a deeper knowledge of Biochemistry.
His research in Biochemistry intersects with topics in Chalcone and Pathogenesis.
His Adenosine research is multidisciplinary, incorporating perspectives in Platelet activation, Platelet, Adenosine A1 receptor and Nucleoside.
His studies in Pharmacology integrate themes in fields like In vitro, Agonist, Partial agonist, Parkinson's disease and Dopamine.
Between 2016 and 2021, his most popular works were:
- Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives. (26 citations)
- 7‐Amino‐2‐aryl/hetero‐aryl‐5‐oxo‐5,8‐dihydro[1,2,4]triazolo[1,5‐a]pyridine‐6‐carbonitriles: Synthesis and adenosine receptor binding studies (19 citations)
- Synthesis and adenosine receptors binding studies of new fluorinated analogues of pyrido[2,3- d ]pyrimidines and quinazolines (19 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Amino acid
- Biochemistry
Karl-Norbert Klotz mainly focuses on Adenosine receptor, Adenosine, Stereochemistry, Pharmacology and Ring.
His work deals with themes such as Docking and Ligand, which intersect with Adenosine receptor.
His studies deal with areas such as Receptor, G protein-coupled receptor, Allosteric regulation, Partial agonist and Tachyphylaxis as well as Adenosine.
His study in Receptor is interdisciplinary in nature, drawing from both Substantia nigra, Neuropathic pain, Dopamine and Medicinal chemistry.
His Pharmacology research is multidisciplinary, incorporating elements of Agonist, Dopaminergic, Antagonist, Parkinson's disease and Ischemia.
His biological study spans a wide range of topics, including Molecular model and Formalin Test.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
